Introduction
Osteonecrosis is the death of bone tissue caused by an interruption in its blood supply. The condition affects the skeletal system, most often the ends of long bones such as the femur, but it can occur in any bone that depends on a limited vascular network. Bone is a living tissue that constantly remodels itself, and that process requires oxygen, nutrients, and removal of waste through blood flow. When circulation is reduced or blocked for long enough, bone cells begin to die, the structural framework weakens, and the affected region may collapse.
Osteonecrosis is therefore not simply “bone damage” in a general sense. It is a vascular disorder of bone, in which impaired perfusion leads to cellular death, failure of normal repair, and progressive structural loss. The biology of the condition involves bone cells, blood vessels, marrow, and the mechanical forces that act on weight-bearing skeleton.
The Body Structures or Systems Involved
The main structure affected in osteonecrosis is the bone itself, especially the subchondral region, which is the layer of bone directly beneath the articular cartilage in a joint. This zone is important because it helps distribute load across the joint surface. When it weakens, the overlying cartilage can lose support even if the cartilage initially remains intact.
Several components of bone are involved. Osteocytes are the mature bone cells embedded within mineralized bone matrix, osteoblasts form new bone, and osteoclasts resorb old bone. These cells work together in the remodeling cycle that maintains skeletal strength. Osteonecrosis interrupts this cycle by killing osteocytes and damaging the marrow and bone-lining cells that regulate repair.
The vascular system is equally central. Bone receives blood through small arteries and microvascular channels that are especially vulnerable to obstruction, compression, or injury. Some bones, such as the femoral head, depend on end arteries with limited collateral circulation, which makes them more sensitive to reduced blood flow. The marrow space is also involved because changes in fat cells, pressure, or clotting within the marrow can further impair perfusion.
How the Condition Develops
Osteonecrosis develops when blood flow to a region of bone falls below the level needed to sustain living tissue. The initiating problem may be vascular obstruction, vessel injury, increased pressure within the bone, or a combination of these factors. Once perfusion drops, oxygen delivery declines and cellular metabolism shifts toward failure. Bone cells cannot survive long without adequate oxygen, and osteocytes are among the first to be affected.
The earliest pathologic event is death of cellular elements in the affected area. Because bone is a dynamic tissue, dead cells do not simply disappear without consequence. The mineralized matrix may persist temporarily, but it becomes biologically inactive and structurally fragile. At the same time, the normal remodeling response attempts to remove dead bone and replace it with new tissue. This creates a mismatch: resorption may occur faster than replacement, leaving the region mechanically weaker.
As the process continues, the marrow space often becomes abnormal as well. Fat cells may enlarge, marrow pressure may rise, and local microcirculation may worsen further. In some cases, small blood clots or endothelial injury contribute to the problem by narrowing vessels and limiting flow. The condition can begin silently, with tissue death already underway before any obvious structural failure occurs.
In weight-bearing bones, mechanical stress then becomes a major factor. Bone weakened by necrosis cannot distribute load normally. Repeated stress during movement concentrates forces in the damaged area, producing microfractures. If the subchondral bone loses support, the surface may collapse inward. This step changes osteonecrosis from a microscopic vascular injury into a clear structural disorder of the joint.
Structural or Functional Changes Caused by the Condition
The most important structural change in osteonecrosis is the loss of viable bone tissue in a localized region. The affected bone may retain its shape for a period, but its internal architecture becomes compromised. Dead osteocytes mean the tissue can no longer regulate remodeling or adapt normally to stress. The trabecular framework, which provides internal support in cancellous bone, may thin, fracture, or become disorganized.
Another major change is collapse of the subchondral plate. Because this layer supports the articular surface, its failure can lead to deformation of the joint contour. Even if the cartilage initially survives, it depends on the bone beneath it for mechanical stability. Once the underlying bone caves in, the joint surface can become uneven and function poorly.
The surrounding tissues also respond. Bone marrow can show edema, hemorrhage, and fibrosis as the process evolves. Repair attempts may generate a zone of reactive bone around the necrotic core, but this does not fully restore strength. The result is a mechanically unstable area that may progress from a small focus of necrosis to a broader region of collapse.
Functionally, the condition alters load transfer through the skeleton. Healthy bone distributes compressive and shear forces across a wide network of living tissue. Necrotic bone behaves more like inert material, unable to remodel in response to stress. This makes the involved region less resilient and increases the likelihood of progressive deformation.
Factors That Influence the Development of the Condition
Many different factors can disrupt bone blood supply or make bone more vulnerable to ischemia. One broad mechanism is vascular compromise. Trauma can directly damage vessels, while vascular injury from inflammatory, metabolic, or clotting disorders can reduce perfusion without a single obvious event. Because bone depends on small blood vessels, even subtle changes in circulation may have significant effects.
Another important mechanism is pressure within the bone and marrow. If intraosseous pressure rises, blood entering the bone is impeded. This can happen when marrow fat cells enlarge, when fluid accumulates, or when local structural changes compress vessels. Reduced outflow can also contribute by increasing venous pressure and making arterial inflow less effective.
Blood chemistry and clotting tendencies can influence risk as well. Conditions that increase coagulability may promote microthrombi in small vessels, which further compromise supply. Disorders that affect lipid metabolism can alter marrow fat behavior and vessel patency. In some situations, corticosteroid exposure is associated with changes in fat cell size, lipid handling, and vascular function, all of which can favor ischemia in bone.
Underlying diseases that affect vessels, such as sickle cell disease or systemic autoimmune disorders, can interfere with perfusion by different mechanisms. In sickle cell disease, abnormal red blood cells can obstruct capillaries and reduce flow. In autoimmune disease, vessel inflammation or clotting abnormalities may impair circulation. Radiation, decompression injury, and certain metabolic states can also damage the microvasculature or bone cells directly.
Variations or Forms of the Condition
Osteonecrosis can be classified in several ways depending on the size, location, and cause of the lesion. One distinction is between localized and more widespread involvement. Localized osteonecrosis affects a single area, often in one joint, while multifocal disease involves multiple sites and suggests a systemic disturbance of blood flow, coagulation, or bone metabolism.
The condition also varies by stage. In early disease, cellular death may be present without obvious collapse of the bone surface. In later disease, structural failure dominates and the subchondral bone may deform. These stages differ not only in appearance but in the underlying biology: early lesions are defined by ischemia and cell death, whereas advanced lesions reflect failed repair and mechanical collapse.
Another form involves the size and geometry of the necrotic region. Small lesions may remain stable for a long time if surrounding bone compensates for the loss. Larger lesions, especially in high-load regions, are more likely to progress because they interrupt a greater portion of the load-bearing architecture. Location matters as well, since bones with limited collateral circulation are more susceptible to infarction than bones with richer vascular networks.
The cause also shapes the pattern of disease. Trauma-related osteonecrosis often follows direct vascular injury, while nontraumatic forms are more likely to involve systemic factors such as altered clotting, marrow fat changes, or chronic steroid exposure. Although the final pathway is similar, the upstream mechanisms differ.
How the Condition Affects the Body Over Time
If osteonecrosis persists, the affected region may undergo a predictable sequence of pathological events. First, there is death of bone cells and persistence of nonviable matrix. Next, the body attempts repair through resorption and new bone formation. Because the repair process is slower and less organized than normal remodeling, the necrotic region can become mechanically weaker before it becomes stronger.
Over time, repeated stress on weakened bone can create microdamage. If the damage accumulates, the subchondral surface may fail. Collapse changes the shape of the bone and alters joint mechanics. Once the surface becomes irregular, the distribution of force across the joint changes, increasing mechanical stress on adjacent cartilage and bone.
Long-term progression can lead to degeneration of the involved joint. Cartilage breakdown, secondary degenerative change, and chronic instability may follow structural collapse. In this setting, the original vascular lesion has expanded into a broader musculoskeletal problem affecting alignment, motion, and load bearing.
The body may respond with sclerosis, fibrotic repair, and reactive bone formation around the necrotic zone. These changes represent an attempt to stabilize the area, but they do not restore the original blood supply or fully reverse the damage. Once a critical portion of the bone architecture has failed, the lesion may remain permanently altered.
Conclusion
Osteonecrosis is the death of bone tissue caused by loss of blood supply, most often in the subchondral region of weight-bearing bones. Its biology centers on ischemia, death of bone cells, failure of normal remodeling, and eventual structural weakening or collapse. The condition involves the bone, marrow, microvasculature, and the mechanical forces that act on the skeleton.
Understanding osteonecrosis requires viewing it as a vascular and structural disorder rather than a simple injury to bone. Its course is shaped by how blood flow is disrupted, how bone cells respond to oxygen deprivation, and how the damaged tissue behaves under load. Those mechanisms explain why the condition can remain silent early on and later progress to major structural failure in the affected bone.